vs
Kosmos Energy Ltd.(KOS)与Pediatrix Medical Group, Inc.(MD)财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Kosmos Energy Ltd.的1.7倍($493.8M vs $294.6M),Pediatrix Medical Group, Inc.同比增速更快(-1.7% vs -25.9%),过去两年Pediatrix Medical Group, Inc.的营收复合增速更高(-0.1% vs -16.5%)
科斯莫斯能源是一家美国上游石油企业,总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务,在毛里塔尼亚、塞内加尔近海拥有开发项目,还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
Pediatrix Medical Group是美国领先的专科医疗服务提供商,核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域,与美国各地医疗机构合作,为女性、新生儿及儿童提供循证专科医疗服务。
KOS vs MD — 直观对比
营收规模更大
MD
是对方的1.7倍
$294.6M
营收增速更快
MD
高出24.2%
-25.9%
两年增速更快
MD
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $294.6M | $493.8M |
| 净利润 | — | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | -125.7% | 9.9% |
| 净利率 | — | 6.8% |
| 营收同比 | -25.9% | -1.7% |
| 净利润同比 | — | 10.5% |
| 每股收益(稀释后) | $-0.80 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KOS
MD
| Q4 25 | $294.6M | $493.8M | ||
| Q3 25 | $311.0M | $492.9M | ||
| Q2 25 | $392.6M | $468.8M | ||
| Q1 25 | $290.1M | $458.4M | ||
| Q4 24 | $397.6M | $502.4M | ||
| Q3 24 | $407.8M | $511.2M | ||
| Q2 24 | $447.8M | $504.3M | ||
| Q1 24 | $422.3M | $495.1M |
净利润
KOS
MD
| Q4 25 | — | $33.7M | ||
| Q3 25 | $-124.3M | $71.7M | ||
| Q2 25 | $-87.7M | $39.3M | ||
| Q1 25 | $-110.6M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $45.0M | $19.4M | ||
| Q2 24 | $59.8M | $-153.0M | ||
| Q1 24 | $91.7M | $4.0M |
营业利润率
KOS
MD
| Q4 25 | -125.7% | 9.9% | ||
| Q3 25 | -34.2% | 13.8% | ||
| Q2 25 | -16.2% | 12.8% | ||
| Q1 25 | -32.4% | 7.0% | ||
| Q4 24 | -8.5% | 7.8% | ||
| Q3 24 | 26.1% | 6.6% | ||
| Q2 24 | 30.2% | -31.3% | ||
| Q1 24 | 33.6% | 3.2% |
净利率
KOS
MD
| Q4 25 | — | 6.8% | ||
| Q3 25 | -40.0% | 14.5% | ||
| Q2 25 | -22.3% | 8.4% | ||
| Q1 25 | -38.1% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 11.0% | 3.8% | ||
| Q2 24 | 13.3% | -30.3% | ||
| Q1 24 | 21.7% | 0.8% |
每股收益(稀释后)
KOS
MD
| Q4 25 | $-0.80 | $0.40 | ||
| Q3 25 | $-0.26 | $0.84 | ||
| Q2 25 | $-0.18 | $0.46 | ||
| Q1 25 | $-0.23 | $0.24 | ||
| Q4 24 | $0.00 | $0.37 | ||
| Q3 24 | $0.09 | $0.23 | ||
| Q2 24 | $0.12 | $-1.84 | ||
| Q1 24 | $0.19 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $91.5M | $375.2M |
| 总债务越低越好 | $3.1B | $570.5M |
| 股东权益账面价值 | $528.6M | $865.9M |
| 总资产 | $4.7B | $2.2B |
| 负债/权益比越低杠杆越低 | 5.78× | 0.66× |
8季度趋势,按日历期对齐
现金及短期投资
KOS
MD
| Q4 25 | $91.5M | $375.2M | ||
| Q3 25 | $64.0M | $340.1M | ||
| Q2 25 | $51.7M | $224.7M | ||
| Q1 25 | $49.8M | $99.0M | ||
| Q4 24 | $85.0M | $229.9M | ||
| Q3 24 | $51.6M | $103.8M | ||
| Q2 24 | $173.8M | $19.4M | ||
| Q1 24 | $254.3M | $8.0M |
总债务
KOS
MD
| Q4 25 | $3.1B | $570.5M | ||
| Q3 25 | $3.0B | $577.2M | ||
| Q2 25 | $2.9B | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $2.7B | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
KOS
MD
| Q4 25 | $528.6M | $865.9M | ||
| Q3 25 | $898.8M | $890.7M | ||
| Q2 25 | $1.0B | $833.8M | ||
| Q1 25 | $1.1B | $789.2M | ||
| Q4 24 | $1.2B | $764.9M | ||
| Q3 24 | $1.2B | $732.5M | ||
| Q2 24 | $1.1B | $706.5M | ||
| Q1 24 | $1.1B | $856.2M |
总资产
KOS
MD
| Q4 25 | $4.7B | $2.2B | ||
| Q3 25 | $5.1B | $2.2B | ||
| Q2 25 | $5.2B | $2.1B | ||
| Q1 25 | $5.3B | $2.0B | ||
| Q4 24 | $5.3B | $2.2B | ||
| Q3 24 | $5.5B | $2.1B | ||
| Q2 24 | $5.4B | $2.0B | ||
| Q1 24 | $5.4B | $2.2B |
负债/权益比
KOS
MD
| Q4 25 | 5.78× | 0.66× | ||
| Q3 25 | 3.31× | 0.65× | ||
| Q2 25 | 2.80× | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 2.29× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $35.3M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
KOS
MD
| Q4 25 | $35.3M | $114.1M | ||
| Q3 25 | $-27.6M | $137.3M | ||
| Q2 25 | $127.2M | $137.2M | ||
| Q1 25 | $-888.0K | $-117.5M | ||
| Q4 24 | $175.7M | $133.0M | ||
| Q3 24 | $6.3M | $91.8M | ||
| Q2 24 | $223.7M | $107.0M | ||
| Q1 24 | $272.6M | $-125.2M |
现金转化率
KOS
MD
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 0.14× | 4.72× | ||
| Q2 24 | 3.74× | — | ||
| Q1 24 | 2.97× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |